180 related articles for article (PubMed ID: 37081792)
21. Melanoma cell autonomous growth: the Rb/E2F pathway.
Halaban R
Cancer Metastasis Rev; 1999; 18(3):333-43. PubMed ID: 10721488
[TBL] [Abstract][Full Text] [Related]
22. Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins.
Swanton C; Mann DJ; Fleckenstein B; Neipel F; Peters G; Jones N
Nature; 1997 Nov; 390(6656):184-7. PubMed ID: 9367157
[TBL] [Abstract][Full Text] [Related]
23. AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity.
Liu Y; Lu C; Shen Q; Munoz-Medellin D; Kim H; Brown PH
Oncogene; 2004 Oct; 23(50):8238-46. PubMed ID: 15378019
[TBL] [Abstract][Full Text] [Related]
24. Low levels of cyclin D and nonfunctional Rb protein affect cdk6 association with cyclin-dependent kinase inhibitor p27(Kip1).
Kwon TK; Park JW
Biochem Biophys Res Commun; 2001 Jun; 284(1):106-11. PubMed ID: 11374878
[TBL] [Abstract][Full Text] [Related]
25. Mechanistic insights into avian reovirus p17-modulated suppression of cell cycle CDK-cyclin complexes and enhancement of p53 and cyclin H interaction.
Chiu HC; Huang WR; Liao TL; Chi PI; Nielsen BL; Liu JH; Liu HJ
J Biol Chem; 2018 Aug; 293(32):12542-12562. PubMed ID: 29907572
[TBL] [Abstract][Full Text] [Related]
26. Cell cycle and biochemical effects of PD 0183812. A potent inhibitor of the cyclin D-dependent kinases CDK4 and CDK6.
Fry DW; Bedford DC; Harvey PH; Fritsch A; Keller PR; Wu Z; Dobrusin E; Leopold WR; Fattaey A; Garrett MD
J Biol Chem; 2001 May; 276(20):16617-23. PubMed ID: 11278443
[TBL] [Abstract][Full Text] [Related]
27. Role of cell cycle regulators in tumor formation in transgenic mice expressing the human neurotropic virus, JCV, early protein.
Krynska B; Gordon J; Otte J; Franks R; Knobler R; DeLuca A; Giordano A; Khalili K
J Cell Biochem; 1997 Nov; 67(2):223-30. PubMed ID: 9328827
[TBL] [Abstract][Full Text] [Related]
28. Degradation of p27(Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex.
Ellis M; Chew YP; Fallis L; Freddersdorf S; Boshoff C; Weiss RA; Lu X; Mittnacht S
EMBO J; 1999 Feb; 18(3):644-53. PubMed ID: 9927424
[TBL] [Abstract][Full Text] [Related]
29. Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs.
Roskoski R
Pharmacol Res; 2019 Jan; 139():471-488. PubMed ID: 30508677
[TBL] [Abstract][Full Text] [Related]
30. Identification of G1 kinase activity for cdk6, a novel cyclin D partner.
Meyerson M; Harlow E
Mol Cell Biol; 1994 Mar; 14(3):2077-86. PubMed ID: 8114739
[TBL] [Abstract][Full Text] [Related]
31. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL
Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508
[TBL] [Abstract][Full Text] [Related]
32. Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product.
Parry D; Bates S; Mann DJ; Peters G
EMBO J; 1995 Feb; 14(3):503-11. PubMed ID: 7859739
[TBL] [Abstract][Full Text] [Related]
33. Increased G1 cyclin/cdk activity in cells overexpressing the candidate oncogene, MCT-1.
Dierov J; Prosniak M; Gallia G; Gartenhaus RB
J Cell Biochem; 1999 Sep; 74(4):544-50. PubMed ID: 10440924
[TBL] [Abstract][Full Text] [Related]
34. Failure of T lymphocytes from elderly humans to enter the cell cycle is associated with low Cdk6 activity and impaired phosphorylation of Rb protein.
Arbogast A; Boutet S; Phelouzat MA; Plastre O; Quadri R; Proust JJ
Cell Immunol; 1999 Oct; 197(1):46-54. PubMed ID: 10555995
[TBL] [Abstract][Full Text] [Related]
35. Cyclin D-CDK4/6 functions in cancer.
Gao X; Leone GW; Wang H
Adv Cancer Res; 2020; 148():147-169. PubMed ID: 32723562
[TBL] [Abstract][Full Text] [Related]
36. Activation of the cyclin D2 and cdk6 genes through NF-kappaB is critical for cell-cycle progression induced by HTLV-I Tax.
Iwanaga R; Ozono E; Fujisawa J; Ikeda MA; Okamura N; Huang Y; Ohtani K
Oncogene; 2008 Sep; 27(42):5635-42. PubMed ID: 18504428
[TBL] [Abstract][Full Text] [Related]
37. S-Phase entry upon ectopic expression of G1 cyclin-dependent kinases in the absence of retinoblastoma protein phosphorylation.
Leng X; Connell-Crowley L; Goodrich D; Harper JW
Curr Biol; 1997 Sep; 7(9):709-12. PubMed ID: 9285720
[TBL] [Abstract][Full Text] [Related]
38. Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells.
Sweeney KJ; Sarcevic B; Sutherland RL; Musgrove EA
Oncogene; 1997 Mar; 14(11):1329-40. PubMed ID: 9178893
[TBL] [Abstract][Full Text] [Related]
39. Stabilization of CDK6 by ribosomal protein uS7, a target protein of the natural product fucoxanthinol.
Iizumi Y; Sowa Y; Goi W; Aono Y; Watanabe M; Kurumida Y; Kameda T; Akaji K; Kitagawa M; Sakai T
Commun Biol; 2022 Jun; 5(1):564. PubMed ID: 35681048
[TBL] [Abstract][Full Text] [Related]
40. Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation.
Watts CK; Brady A; Sarcevic B; deFazio A; Musgrove EA; Sutherland RL
Mol Endocrinol; 1995 Dec; 9(12):1804-13. PubMed ID: 8614416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
